Insider Transactions in Q4 2021 at Bioxytran, Inc (BIXT)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2021
|
David Platt CEO |
BUY
Grant, award, or other acquisition
|
Indirect |
2,068,563
+50.0%
|
-
|
|
Dec 03
2021
|
Michael Sheikh Chief Communications Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
599,517
+50.0%
|
-
|
|
Dec 03
2021
|
Ola Soderquist CFO |
BUY
Grant, award, or other acquisition
|
Indirect |
1,340,749
+50.0%
|
-
|
|
Nov 29
2021
|
Hana Chen Walden Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+9.75%
|
-
|
|
Nov 29
2021
|
Alan M Hoberman Director |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+15.26%
|
-
|
|
Nov 29
2021
|
Anders Utter Director |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+17.02%
|
-
|
|
Nov 29
2021
|
Dale H Conaway Director |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+17.75%
|
-
|
|
Nov 19
2021
|
David Platt CEO |
SELL
Bona fide gift
|
Direct |
3,201,788
-6.93%
|
$0
$0.14 P/Share
|
|
Nov 19
2021
|
Michael Sheikh Chief Communications Officer |
SELL
Bona fide gift
|
Indirect |
400,000
-100.0%
|
$0
$0.48 P/Share
|
|
Nov 19
2021
|
Michael Sheikh Chief Communications Officer |
SELL
Bona fide gift
|
Direct |
1,871,085
-17.53%
|
$0
$0.14 P/Share
|
|
Nov 19
2021
|
Ola Soderquist CFO |
SELL
Bona fide gift
|
Direct |
3,201,788
-12.06%
|
$0
$0.14 P/Share
|